Processa Pharmaceuticals, Inc. current report, 17 September 2015

Business Context and Reporting Period

This Form 8-K was filed by Heatwurx, Inc. (OTC: HUWX) on September 17, 2015. The filing reports the resignation of two directors and the Company's decision to liquidate substantially all assets and settle liabilities after failing to secure a merger or sufficient revenue through its asphalt repair equipment and service business model.

Key Financial Metrics

Based on the quarter ended June 30, 2015:

  • Total Assets: $877,714
  • Total Liabilities: $2,198,213
  • Net Worth: Negative (Liabilities exceed assets by approximately $1.32 million)
  • Liquidity: The Company requires substantial additional operating capital, and future viability is uncertain.

The filing does not provide specific revenue, profit, or cash flow figures for the current period; investors are directed to the most recent Form 10-Q for detailed financial statements.

Material Changes

  • Management Changes: Donald Larson and Gus Blass III resigned as directors on September 15, 2015. John P. McGrain was appointed Interim CEO, Interim CFO, and Board member.
  • Strategic Shift: The Company abandoned its search for a merger candidate following the review of several unsuitable proposals. It has now elected to liquidate assets and settle debts.
  • Operational Status: The Company has been unsuccessful in identifying outside officers to lead operations and is reducing monthly expenditures.

Outlook, Risks, and Contingencies

The Company intends to remain a public entity and may seek future merger candidates, though it provides no assurances of success. Key risks include:

  • Uncertain future viability due to a lack of operating capital.
  • Failure to achieve desired revenue traction from equipment sales, service work, or franchising.
  • Ongoing monthly expenses related to financed equipment and leased office space.
  • Reliance on a consultant to assist in the orderly sale of assets and debt reduction.

Investor Verification Checklist

  • Verify the details of the asset liquidation plan and expected timeline.
  • Review the most recent Form 10-Q for detailed revenue, cash flow, and debt maturity schedules.
  • Confirm the status of the $2.2 million in liabilities and the priority of creditor claims.
  • Monitor for updates regarding the appointment of permanent management or new merger proposals.